Large-Cap Stocks: GE HealthCare to Sell, Carvana and McKesson to Watch
PorAinvest
lunes, 14 de julio de 2025, 4:21 am ET1 min de lectura
CVNA--
GEHC's stock has observed a 1.8% dip over the past 52 weeks, underperforming the Health Care Select Sector SPDR Fund (XLV), which has declined by 6.5%, and the S&P 500 Index ($SPX), which has seen a 12.3% drop [1]. The company reported a strong start to the year, with its stock prices gaining 3.3% after the release of its Q1 results on April 30. Organic revenues grew by 2.7% year-over-year to $4.8 billion, driven by strengthening sales in the U.S. [1].
For the full fiscal 2025, analysts expect GEHC to deliver an EPS of $4.02, down 10.5% from $4.49 reported in the previous year. In fiscal 2026, its earnings are expected to rebound by 12.2% year-over-year to $4.51 per share [1]. Despite these projections, the company's stock holds a consensus "Strong Buy" rating, with 13 analysts rating it as a "Strong Buy," one as a "Moderate Buy," and five as a "Hold." The mean price target of $87.16 suggests a 15.4% upside potential from current price levels [1].
In contrast, Carvana (CVNA) and McKesson (MCK) are large-cap stocks to watch. Carvana has seen growing retail units sold and highly profitable incremental sales, making it an attractive stock for investors. McKesson, with a long history and a diversified healthcare services business, also presents opportunities for growth [2].
References:
[1] https://finance.yahoo.com/news/know-ahead-ge-healthcare-technologies-071630284.html
[2] https://www.tradingview.com/news/gurufocus:65c90b6f2094b:0-healthcare-services-group-slides-on-genesis-bankruptcy/
GE--
GEHC--
MCK--
GE HealthCare (GEHC) is a large-cap stock to sell due to sluggish demand and flat earnings per share. Carvana (CVNA) is a large-cap stock to watch with growing retail units sold and highly profitable incremental sales. McKesson (MCK) is another large-cap stock to watch, with a long history and a diversified healthcare services business.
GE HealthCare Technologies Inc. (GEHC), a leading designer of medical imaging and patient-monitoring products, is facing challenges that may warrant a sell signal for investors. The company, valued at $34.4 billion by market cap, is set to release its second-quarter results on July 30. Analysts expect a profit of $0.91 per share, down 9% from the $1 per share reported in the year-ago quarter. Despite this expected decline, GEHC has a history of surpassing earnings estimates, having done so in each of the past four quarters [1].GEHC's stock has observed a 1.8% dip over the past 52 weeks, underperforming the Health Care Select Sector SPDR Fund (XLV), which has declined by 6.5%, and the S&P 500 Index ($SPX), which has seen a 12.3% drop [1]. The company reported a strong start to the year, with its stock prices gaining 3.3% after the release of its Q1 results on April 30. Organic revenues grew by 2.7% year-over-year to $4.8 billion, driven by strengthening sales in the U.S. [1].
For the full fiscal 2025, analysts expect GEHC to deliver an EPS of $4.02, down 10.5% from $4.49 reported in the previous year. In fiscal 2026, its earnings are expected to rebound by 12.2% year-over-year to $4.51 per share [1]. Despite these projections, the company's stock holds a consensus "Strong Buy" rating, with 13 analysts rating it as a "Strong Buy," one as a "Moderate Buy," and five as a "Hold." The mean price target of $87.16 suggests a 15.4% upside potential from current price levels [1].
In contrast, Carvana (CVNA) and McKesson (MCK) are large-cap stocks to watch. Carvana has seen growing retail units sold and highly profitable incremental sales, making it an attractive stock for investors. McKesson, with a long history and a diversified healthcare services business, also presents opportunities for growth [2].
References:
[1] https://finance.yahoo.com/news/know-ahead-ge-healthcare-technologies-071630284.html
[2] https://www.tradingview.com/news/gurufocus:65c90b6f2094b:0-healthcare-services-group-slides-on-genesis-bankruptcy/

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios